CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 95 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $7,640,975 | -12.5% | 1,308,386 | +0.3% | 0.00% | 0.0% |
Q3 2022 | $8,737,000 | +70.0% | 1,303,995 | +6.8% | 0.00% | 0.0% |
Q2 2022 | $5,138,000 | +51.4% | 1,220,541 | +21.2% | 0.00% | – |
Q1 2022 | $3,393,000 | +6.9% | 1,006,959 | -0.0% | 0.00% | – |
Q4 2021 | $3,173,000 | -2.9% | 1,007,258 | +0.8% | 0.00% | – |
Q3 2021 | $3,267,000 | -23.1% | 999,254 | -0.7% | 0.00% | – |
Q2 2021 | $4,246,000 | -17.5% | 1,006,158 | -2.4% | 0.00% | -100.0% |
Q1 2021 | $5,146,000 | -78.3% | 1,031,092 | -45.1% | 0.00% | -66.7% |
Q4 2020 | $23,729,000 | +29.3% | 1,877,328 | +0.4% | 0.00% | +50.0% |
Q3 2020 | $18,358,000 | -1.2% | 1,869,374 | +0.1% | 0.00% | -33.3% |
Q2 2020 | $18,583,000 | +12.7% | 1,867,643 | +0.1% | 0.00% | 0.0% |
Q1 2020 | $16,495,000 | -0.1% | 1,865,926 | +4.2% | 0.00% | +50.0% |
Q4 2019 | $16,514,000 | +92.7% | 1,790,166 | +22.8% | 0.00% | +100.0% |
Q3 2019 | $8,571,000 | -6.3% | 1,457,581 | +91.1% | 0.00% | 0.0% |
Q2 2019 | $9,151,000 | +583.9% | 762,606 | +587.5% | 0.00% | – |
Q1 2019 | $1,338,000 | +161.3% | 110,922 | +171.7% | 0.00% | – |
Q4 2018 | $512,000 | +3.4% | 40,819 | +22.5% | 0.00% | – |
Q3 2018 | $495,000 | -11.3% | 33,328 | +0.3% | 0.00% | – |
Q2 2018 | $558,000 | -43.8% | 33,213 | -23.3% | 0.00% | – |
Q1 2018 | $993,000 | -42.2% | 43,330 | -34.8% | 0.00% | – |
Q4 2017 | $1,719,000 | +142.5% | 66,464 | +38.3% | 0.00% | – |
Q3 2017 | $709,000 | +2.5% | 48,068 | -3.2% | 0.00% | – |
Q2 2017 | $692,000 | -34.5% | 49,639 | -19.9% | 0.00% | – |
Q1 2017 | $1,057,000 | +65.2% | 61,955 | -0.4% | 0.00% | – |
Q4 2016 | $640,000 | +7.4% | 62,181 | +5.5% | 0.00% | – |
Q3 2016 | $596,000 | -9.3% | 58,921 | +0.7% | 0.00% | – |
Q2 2016 | $657,000 | -13.0% | 58,498 | +5.9% | 0.00% | – |
Q1 2016 | $755,000 | -63.5% | 55,255 | -49.4% | 0.00% | – |
Q4 2015 | $2,071,000 | +10.3% | 109,170 | +9.1% | 0.00% | – |
Q3 2015 | $1,878,000 | +26.1% | 100,054 | +0.0% | 0.00% | – |
Q2 2015 | $1,489,000 | -1.7% | 100,006 | +0.0% | 0.00% | -100.0% |
Q1 2015 | $1,515,000 | +1546.7% | 100,000 | +1340.9% | 0.00% | – |
Q4 2014 | $92,000 | -67.8% | 6,940 | -75.5% | 0.00% | – |
Q2 2014 | $286,000 | – | 28,310 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |